CAS 152685-91-1: cimiside B

Cimiside B is a glycoside alkaloid isolated from the rhizome of Cimicifuga dahurica.

Cimiside B is a triterpenoid saponin, which is a complex compound derived from the roots of Cimicifuga species, specifically within the Ranunculaceae family. This natural product is part of a group of phytochemicals known for their diverse biological activities. The mode of action of Cimiside B involves the disruption of cellular processes, potentially through the modulation of specific intracellular pathways that can lead to cell apoptosis or affect cell cycle regulation. This makes it a molecule of interest in the realm of cancer research. The potential uses and applications of Cimiside B are primarily in the study of its anticancer and chemopreventive properties. By understanding how Cimiside B interacts at the molecular level, it opens doors for novel therapeutic strategies and provides a basis for the synthesis of new drugs that could target resistant cancer cells. Furthermore, its role as a natural compound offers an alternative approach, complementing synthetic chemotherapeutic agents.